Evidence map›Paper›PMID 42494266›Full record

ArticleYonsei medical journal2026

Effects of COVID-19 Control Policies on Malaria Surveillance: A Comparative Analysis of North and South Korea.

Jong-Hun Kim, Jisun Sung

Abstract readComparative Study
In one paragraph

Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jong-Hun KimDepartment of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea. kimjh32@skku.edu.ORCID https://orcid.org/0000-0002-4974-5180
Jisun SungDepartment of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-7345-9969

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBoth South and North Korea are identified by the World Health Organization (WHO) as having the potential to eliminate malaria. However, the increase in malaria cases during the COVID-19 response has prompted an investigation into the reasons behind this unexpected rise. MATERIALS AND

methodsEpidemiological, entomological, and meteorological data from national and international surveillance systems were analyzed. Using the WHO's analytical framework, which can be effectively applied during the elimination phase, we assessed drivers of malaria resurgence in North and South Korea.

resultsIn North Korea, border closures caused a severe shortage of rapid diagnostic test kits, reducing malaria testing by over 90% by 2021. Microscopy use increased but remained insufficient, while confirmed cases rose from 1819 in 2020 to 3160 in 2023. In South Korea, public health resources were diverted to COVID-19, weakening malaria control activities. The response time for epidemiological investigations increased from 1.3 days in 2019 to 4.3 days in 2021. Relapse cases, which were zero in 2021, increased to eight in 2023, and confirmed cases rose from 274 in 2021 to 673 in 2023. There were no meaningful changes in the drivers of malaria resurgence, including importation of malaria parasites or human susceptibility. With no notable shifts in vector density, variations in temperature and precipitation did not explain the rise in either country, and there were no reports of emerging resistance to insecticides or antimalarial drugs.

conclusionThese COVID-19-related disruptions, including supply chain failures and the diversion of human resources, impaired malaria control in countries on the Korean Peninsula.

Indexed as

COVID-19MalariaAnimalsDemocratic People's Republic of KoreaHumansRepublic of KoreaSARS-CoV-2COVID-19MalariaNorth KorearesurgenceSouth Koreastrategy

Identifiers

PMID42494266
PMCPMC13407057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.